SCHEMBL8338337

SCHEMBL8338337

CNC(=S)NC(=O)C(CCC(C)N=S(=O)=O)c1ccc(C)cc1

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ CNR2 P34972 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ ACHE P22303 1/20 0.30
▸ ALOX5 P09917 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ KEAP1 Q14145 1/20 0.30
▸ NFE2L2 Q16236 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8337813 0.88 TDP1 (0.39) GAAALDH1A1RAB9ACNR1CNR2
SCHEMBL8338863 0.86 ALDH1A1 (0.35) GAAALDH1A1SMN1; SMN2CNR1CNR2
SCHEMBL8339878 0.85 ALDH1A1 (0.33) GAAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8340341 0.84 KDM4E (0.36) GAAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8335548 0.83 KDM4E (0.35) GAAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8339028 0.81 GAA (0.33) GAAALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL8340346 0.80 ALOX5 (0.32) ALOX5LMNA
SCHEMBL8338089 0.76 TDP1 (0.37) GAAALDH1A1RAB9ACNR1CNR2
SCHEMBL8341296 0.75 TDP1 (0.40) GAAALDH1A1SMN1; SMN2CNR1CNR2
SCHEMBL8340160 0.75 MAPT (0.37) GAAALDH1A1CNR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback